Effect of starter unit availability on the spectrum of manumycin-type metabolites produced by Streptomyces nodosus ssp. asukaensis

Journal of Applied Microbiology

Volumn 111, Issue 5, 2011, Pages 1116-1128

  Pospisil S ^a   Petrickova K ^a   Sedmera, P ^a   Halada, P ^a   Olsovska J ^a   Petricek M ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

Analogue; Asukamycin; Manumycin antibiotics; Polyketide synthase specificity; Precursor directed biosynthesis

Indexed keywords

BACTERIA; BIOCHEMISTRY; BIOSYNTHESIS; FEEDING; GENES; KETONES; METABOLITES; STARTERS;

ANALOG; ASUKAMYCIN; CYCLOHEXANECARBOXYLIC ACIDS; MANUMYCIN ANTIBIOTIC; MUTANT STRAIN; POLYKETIDE SYNTHASE SPECIFICITY; POLYKETIDE SYNTHASES; POLYKETIDES; PRECURSOR FEEDING; PRECURSOR-DIRECTED BIOSYNTHESIS;

CHAINS;

ASUKAMYCIN; ASUKAMYCIN I; COENZYME A; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; MANUMYCIN; MANUMYCIN E; MANUMYCIN G; NORLEUCINE; POLYKETIDE; UNCLASSIFIED DRUG;

ANTIBIOTICS; ENZYME ACTIVITY; GENE EXPRESSION; INHIBITOR; METABOLITE; MUTATION;

ARTICLE; ASUKAMYCIN H; BACTERIAL STRAIN; BIOSYNTHESIS; GENE EXPRESSION; GENE INACTIVATION; GENETIC MANIPULATION; HETEROLOGOUS EXPRESSION; METABOLITE; MUTANT; NONHUMAN; STREPTOMYCES; STREPTOMYCES NODOSUS ASUKAENSIS; TECHNIQUE;

STREPTOMYCES NODOSUS;

EID: 80054686056     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2011.05132.x     Document Type: Article

References (32)

1. Ali, B.R., Pal, A., Croft, S.L., Taylor, R.J. and Field, M.C. (1999) The farnesyltransferase inhibitor manumycin A is a novel trypanocide with a complex mode of action including major effects on mitochondria. Mol Biochem Parasitol 104, 67-80.
2. Bernier, M., Kwon, Y.K., Pandey, S.K., Zhu, T.N., Zhao, R.J., Maciuk, A., He, H.J., Decabo, R. et al. (2006) Binding of manumycin A inhibits IkB kinase b activity. J Biol Chem 281, 2551-2561.
3. Chatterjee, S., Vijayakumar, E.K., Franco, C.M., Blumbach, J., Ganguli, B.N., Fehlhaber, H.-W. and Kogler, H. (1993) On the structure of alisamycin, a new member of the manumycin class of antibiotics. J Antibiot (Tokyo) 46, 1027-1030.
4. Chen, S., von Bamberg, D., Hale, V., Breuer, M., Hardt, B., Müller, R., Floss, H.G., Reynolds, K.A. et al. (1999) Biosynthesis of ansatrienin (mycotrienin) and naphthomycin. Identification and analysis of two separate biosynthetic gene clusters in Streptomyces collinus Tü 1892. Eur J Biochem 261, 98-107.
5. Costantini, C., Weindruch, R., Della, V.G. and Puglielli, L. (2005) A TrkA-to-p75NTR molecular switch activates amyloid b-peptide generation during aging. Biochem J 391, 59-67.
6. Cropp, T.A., Wilson, D.J. and Reynolds, K.A. (2000) Identification of a cyclohexylcarbonyl CoA biosynthetic gene cluster and application in the production of doramectin. Nat Biotechnol 18, 980-983.
7. Denoya, C.D., Fedechko, R.W., Hafner, E.W., Mcarthur, H.A.I., Morgenstern, M.R., Skinner, D.D., Stutzmanengwall, K., Wax, R.G. et al. (1995) A second branched-chain a-keto acid dehydrogenase gene cluster (bkdFGH) from Streptomyces avermitilis: its relationship to avermectin biosynthesis and the construction of a bkdF mutant suitable for the production of novel antiparasitic avermectins. J Bacteriol 177, 3504-3511.
8. Franco, C.M.M., Maurya, R., Vijayakumar, E.K., Chatterjee, S., Blumbach, J. and Ganguli, B.N. (1991) Alisamycin, a new antibiotic of the manumycin group. I. Taxonomy, production, isolation and biological activity. J Antibiot (Tokyo) 44, 1289-1293.
9. Gregory, M.A., Petkovic, H., Lill, R.E., Moss, S.J., Wilkinson, B., Gaisser, S., Leadlay, P.F. and Sheridan, R.M. (2005) Mutasynthesis of rapamycin analogues through the manipulation of a gene governing starter unit biosynthesis. Angew Chem Int Ed Engl 44, 4757-4760.
10. Hara, M., Akasaka, K., Akinaga, S., Okabe, M., Nakano, H., Gomez, R., Wood, D., Uh, M. et al. (1993) Identification of Ras farnesyltransferase inhibitors by microbial screening. Proc Natl Acad Sci USA 90, 2281-2285.
11. Heide, L. (2009) Genetic engineering of antibiotic biosynthesis for the generation of new aminocoumarins. Biotechnol Adv 27, 1006-1014.
12. Hopwood, D.A., Bibb, M.J., Chater, K.F., Kieser, T., Bruton, C.J., Kieser, H.M., Lydiate, D.J., Ward, J.M. et al. (1985) Genetic Manipulation of Streptomyces. A Laboratory Manual. Norwich, UK: The John Innes Foundation.
13. Hu, Y. (2000) The biosynthesis of manumycin type metabolites. PhD thesis, Department of Chemistry, University of Washington, Seattle, WA.
14. Hu, Y.D. and Floss, H.G. (2004) Further studies on the biosynthesis of the manumycin-type antibiotic, asukamycin, and the chemical synthesis of protoasukamycin. J Am Chem Soc 126, 3837-3844.
15. Hu, Y.D. and Floss, H.G. (2006) Starter unit specificity of the asukamycin "upper" chain polyketide synthase and the branched-chain fatty acid synthase of Streptomyces nodosus ssp. asukaensis. Heterocycles 69, 133-149.
16. Kieser, T., Bibb, M.J., Buttner, M.J., Chater, K. and Hopwood, D. (2000) Practical Streptomyces Genetics. Norwich, UK: The John Innes Foundation.
17. Moore, B.S. and Hertweck, C. (2002) Biosynthesis and attachment of novel bacterial polyketide synthase starter units. Nat Prod Rep 19, 70-99.
18. Palmer, B.R. and Marinus, M.G. (1994) The dam and dcm strains of Escherichia coli- a review. Gene 143, 1-12.
19. Petricek, M., Petrickova, K., Havlicek, L. and Felsberg, J. (2006) Occurrence of two 5-aminolevulinate biosynthetic pathways in Streptomyces nodosus ssp. asukaensis is linked with the production of asukamycin. J Bacteriol 188, 5113-5123.
20. Petrickova, K., Markova, A. and Petricek, M. (2008) Nucleic acid for the preparation of a strain producing manumycin. CZ Patent No. 299943.
21. Rui, Z., Petrickova, K., Skanta, F., Pospisil, S., Yang, Y., Chen, C.Y., Tsai, S.F., Floss, H.G. et al. (2010) Biochemical and genetic insights into asukamycin biosynthesis. J Biol Chem 285, 24915-24924.
22. Sattler, I., Gröne, C. and Zeeck, A. (1993) New compounds of the manumycin group of antibiotics and a facilitated route for their structure elucidation. J Org Chem 58, 6583-6587.
23. Sattler, I., Thiericke, R. and Zeeck, A. (1998) The manumycin-group metabolites. Nat Prod Rep 15, 221-240.
24. Sears, K.T., Daino, H. and Carey, G.B. (2008) Reactive oxygen species-dependent destruction of MEK and Akt in Manumycin stimulated death of lymphoid tumor and myeloma cell lines. Int J Cancer 122, 1496-1505.
25. She, M., Yang, H., Sun, L. and Yeung, S.C. (2006) Redox control of manumycin A-induced apoptosis in anaplastic thyroid cancer cells: involvement of the xenobiotic apoptotic pathway. Cancer Biol Ther 5, 275-280.
26. Shima, J., Hesketh, A., Okamoto, S., Kawamoto, S. and Ochi, K. (1996) Induction of actinorhodin production by rpsL (encoding ribosomal protein S12) mutations that confer streptomycin resistance in Streptomyces lividans and Streptomyces coelicolor A3(2). J Bacteriol 178, 7276-7284.
27. Stirrett, K., Denoya, C. and Westpheling, J. (2009) Branched-chain amino acid catabolism provides precursors for the Type II polyketide antibiotic, actinorhodin, via pathways that are nutrient dependent. J Ind Microbiol Biotechnol 36, 129-137.
28. Tanaka, T., Tsukuda, E., Uosaki, Y. and Matsuda, Y. (1996) EI-1511-3, -5 and EI-1625-2, novel interleukin-1 b converting enzyme inhibitors produced by Streptomyces sp. E-1511 and E-1625. III. Biochemical properties of EI-1511-3, -5 and EI-1625-2. J Antibiot (Tokyo) 49, 1085-1090.
29. Thiericke, R., Zeeck, A., Nakagawa, A., Omura, S., Herrold, R.E., Wu, S.T.S., Beale, J.M. and Floss, H.G. (1990) Biosynthesis of the manumycin group antibiotics. J Am Chem Soc 112, 3979-3987.
30. Uosaki, Y., Agatsuma, T., Tanaka, T. and Saitoh, Y. (1996) EI-1511-3, -5 and EI-1625-2, novel interleukin-1 beta converting enzyme inhibitors produced by Streptomyces sp. E-1511 and E-1625. II. Structure determination. J Antibiot (Tokyo) 49, 1079-1084.
31. Weissman, K.J. (2007) Mutasynthesis-uniting chemistry and genetics for drug discovery. Trends Biotechnol 25, 139-142.
32. Zeeck, A., Schroder, K., Frobel, K., Grote, R. and Thiericke, R. (1987) The structure of manumycin. I. Characterization, structure elucidation and biological activity. J Antibiot (Tokyo) 40, 1530-1540.